Homocysteine and left ventricular hypertrophy in children with chronic renal failure

Pediatric Nephrology

Volumn 19, Issue 2, 2004, Pages 193-198

  Poyrazoǧlu, Hakan M ^a   Düşünsel, Ruhan ^a   Narin, Figen ^a   Gündüz, Zübeyde ^a   Narin, Nazmi ^a   Karakükçü, Musa ^a   Tahan, Fulya ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Chronic renal failure; Homocysteine; Left ventricular hypertrophy

Indexed keywords

HEMOGLOBIN; HOMOCYSTEINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CHILDHOOD DISEASE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART INDEX; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERHOMOCYSTEINEMIA; LINEAR REGRESSION ANALYSIS; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; CHILD; CREATININE; ECHOCARDIOGRAPHY; HOMOCYSTINE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; RISK FACTORS;

EID: 0842323866     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1351-6     Document Type: Article

References (31)

1. Parfrey PS, Foley RN, Harnett JD, Kent GM, Murray DC, Barre PE (1996) Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol Dial Transplant 11:1277-1285
2. Schärer K, Schmidt KG, Soergel M (1999) Cardiac function and structure in patients with chronic renal failure. Pediatr Nephrol 13:951-965
3. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PWF, Wright JT (1998) Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32:853-906
4. Chauveau P, Chadefaux B, Coude M, Aupetit J, Hannedouche T, Kamoun P, Jungers P (1993) Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 43 [Suppl 41]:72-77
5. Blacher J, Demuth K, Guerin AP, Vadez C, Moatti N, Safar ME, London GM (1999) Association between plasma homocysteine concentrations and cardiac hypertrophy in end-stage renal disease. J Nephrol 12:248-255
6. Bostom AG, Culleton BF (1999) Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 10:891-900
7. Perna AF, Castaldo P, Ingrosso D, De santo NG (1999) Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin. J Nephrol 12:230-240
8. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450-458
9. Daniels SR, Meyer RA, Liang YC, Bove KE (1988) Echocardiographically determined left ventricular mass index in normal children, adolescents and young adults. J Am Coll Cardiol 12:703-708
10. Levey AS, Eknoyan G (1999) Cardiovascular disease in chronic renal disease. Nephrol Dial Transplant 14:828-833
11. Loirat C, Ehrich IMH, Geerlings W, Jones EHP, Landais P, Mallick NP, Margreiter R, Raine AEG, Salmela K, Selwood N (1994) Report on management of renal failure in children in Europe XXII, 1992. Nephrol Dial Transplant 12:1557-1560
12. Morris KM, Skinner JR, Hunter S, Coulthard MG (1994) Cardiovascular abnormalities in end-stage renal failure: the effect of anaemia or uraemia. Arch Dis Child 71:119-122
13. Johnstone LM, Jones CL, Grigg LE, Wilkinson JL, Walker RG, Powell HR (1996) Left ventricular abnormalities in children, adolescents and young adults with renal disease. Kidney Int 50:998-1006
14. O'Regan S, Douste-Blazy MY, Ducharme G, Fouron JC, Davignon A (1982) Renal transplantation and cardiac function in pediatric patients. Clin Nephrol 17:237-240
15. Moon KH, Song IS, Yang WS, Shin YT, Kim SB, Song JK, Park JS (2000) Hypoalbuminemia as a risk factor for progressive left-ventricular hypertrophy in hemodialysis patients. Am J Nephrol 20:396-401
16. Guldener C van, Janssen MJ, Lambert J, Wee PM ter, Donker AJ, Stehouwer CD (1998) Folic acid treatment of hyperhomocysteinemia in peritoneal dialysis patients: no change in endothelial function after long-term therapy. Perit Dial Int 18:282-289
17. Gupta A, Robinson K (1997) Hyperhomocysteinaemia and end stage renal disease. J Nephrol 10:77-84
18. Bostom AG, Lathrop L (1997) Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10-20
19. Lilien M, Duran M, Hoeck K van, Poll-The BT, Schröder C (1999) Hyperhomocyst(e)inaemia in children with chronic renal failure. Nephrol Dial Transplant 14:366-368
20. Merouani A, Lambert M, Delvin EE, Genest J Jr, Robitaille P, Rozen R (2001) Plasma homocysteine concentration in children with chronic renal failure. Pediatr Nephrol 16:805-811
21. Kang HG, Lee BS, Hahn H, Lee JH, Ha IS, Cheong HI, Choi Y (2002) Reduction of plasma homocysteine by folic acid in children with chronic renal failure. Pediatr Nephrol 17:511-514
22. Feinstein S, Sela BA, Drukker A, Becker-Cohen R, Raveh D, Gavendo S, Frishberg Y (2002) Hyperhomocysteinemia in children on renal replacement therapy. Pediatr Nephrol 17:515-519
23. Hultberg B, Andersson A, Sterner G (1993) Plasma homocysteine in renal failure. Clin Nephrol 401:230-234
24. Wilcken DEL, Dudman NPB, Tyrrell PA, Robertson MR (1988) Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: possible implications for prevention of vascular disease. Metabolism 37:697-701
25. Fodinger M, Mannhalter C, Wolfl G, Pabinger I, Muller E, Schmid R, Horl WH, Sunder-Plassmann G (1997) Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int 52:517-523
26. Bostom AG, Shemin D, Lapane KL, Nadeau MR, Sutherland P, Chan J, Rozen R, Yoburn D, Jacques PF, Selhub J, Rosenberg IH (1996) Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis 123:193-202
27. Bostom AG, Shemin D, Lapane KL, Hume AL, Yoburn D, Nadeau MR, Bendich A, Selhub J, Rosenberg IH (1996) High dose B vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 49:147-152
28. Ducloux D, Heuze-Lecornu L, Gibey R, Bresson-Vautrin C, Vautrin P, Chalopin JM (1999) Dialysis adequacy and homocyst(e)ine concentrations in peritoneal dialysis patients. Nephrol Dial Transplant 14:728-731
29. Sirrs S, Duncan L, Djurdjev O, Nussbaumer G, Ganz G, Frohlich J, Levin A (1999) Homocyst(e)ine and vascular access complications in hemodialysis patients: insights into a complex metabolic relationship. Nephrol Dial Transplant 14:738-743
30. Jungers P, Joly D, Massy Z, Chauveau P, Nguyen AT, Aupetit J, Chadefaux B (1999) Sustained reduction of hyperhomocysteinaemia with folic acid supplementation in predialysis patients. Nephrol Dial Transplant 14:2903-2906
31. Strong JP, Zieske AW, Malcom GT (2001) Lipoproteins and atherosclerosis in children: an early marriage? Nutr Metab Cardiovasc Dis 11 [Suppl 5]:16-22